Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: A cross‐sectional screening of fifty‐four prospectively followed patients
Open Access
- 29 February 2008
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 59 (3), 422-430
- https://doi.org/10.1002/art.23315
Abstract
Objective Giant cell arteritis (GCA) may involve the aorta. Retrospective studies have demonstrated a higher prevalence of aortic aneurysm among patients with GCA compared with the general population. We investigated the prevalence of aortic aneurysm in a cohort of patients with biopsy‐proven GCA using a defined protocol and assessed whether persisting low‐grade disease activity is associated with higher risk of developing aortic aneurysm. Methods Fifty‐four patients with GCA (14 men and 40 women) were cross‐sectionally evaluated after a median followup of 5.4 years (range 4.0–10.5 years). The screening protocol included a chest radiograph, abdominal ultrasonography scan, and computed tomography scan when aortic aneurysm was suspected or changes with respect to the baseline chest radiograph were observed. Clinical and laboratory data, corticosteroid requirements, and relapses were prospectively recorded. Results Twelve patients (22.2%) had significant aortic structural damage (aneurysm/dilatation), 5 of them candidates for surgical repair. Aortic aneurysm/dilatation was more frequent among men (50%) than women (12.5%; relative risk 3.5, 95% confidence interval 1.53–8.01, P = 0.007). At the time of screening, patients with aneurysm/dilatation had lower serum acute‐phase reactants, lower relapse rate, and needed shorter periods to withdraw prednisone than patients without aortic structural damage. Conclusion There is a substantial risk of developing aortic aneurysm/dilatation among patients with GCA. Our data do not support that aneurysm formation mainly results from persistent detectable disease activity. Additional factors including characteristics of the initial injury or the target tissue may also determine susceptibility to aortic aneurysm/dilatation.Keywords
This publication has 30 references indexed in Scilit:
- Gelatinase expression and proteolytic activity in giant-cell arteritisAnnals Of The Rheumatic Diseases, 2007
- Repetitive 18F‐fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patientsArthritis Care & Research, 2006
- Gender Differences in Rat Aortic Smooth Muscle Cell Matrix Metalloproteinase-9Journal of the American College of Surgeons, 2005
- Dual function of focal adhesion kinase in regulating integrin‐induced MMP‐2 and MMP‐9 release by human T lymphoid cellsThe FASEB Journal, 2005
- Metalloproteinase-2 and -9 in Giant Cell ArteritisCirculation, 2005
- Surgical Treatment of Ascending Aortic Aneurysms in Patients With Giant Cell AortitisThe Annals of Thoracic Surgery, 2005
- Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitisRheumatology, 2005
- Increased Tissue Microarray Matrix Metalloproteinase Expression Favors Proteolysis in Thoracic Aortic Aneurysms and DissectionsThe Annals of Thoracic Surgery, 2004
- Gender Differences in Experimental Aortic Aneurysm FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritisArthritis Care & Research, 2002